Stem Cell & Regenerative Medicine

Commercialization, Biobanking & Industry Innovations

Commercialization and biobanking are pivotal in scaling regenerative medicine from laboratory research to clinical applications. Biobanks provide standardized, high-quality stem cell and tissue samples essential for research and therapy. Innovations in manufacturing, logistics, and regulatory compliance support industrial-scale production. Strategic partnerships between academia, biotech, and industry accelerate translation and commercialization. This session highlights challenges in intellectual property, market adoption, and cost-effectiveness. Attendees explore cutting-edge industrial applications, scalable solutions, and business models that drive sustainable growth in regenerative medicine.